Literature DB >> 20364064

Relationship between C-reactive protein and early activation of leukocytes indicated by leukocyte antisedimentation rate (LAR) in patients with acute cerebrovascular events.

Tihamer Molnar1, Viktoria Papp, Miklos Banati, Laszlo Szereday, Gabriella Pusch, Laszlo Szapary, Lajos Bogar, Zsolt Illes.   

Abstract

The purpose of this study was to determine the relationship between high-sensitive C-reactive protein (hsCRP) and leukocyte antisedimentation rate (LAR) as a specific test to detect early activation of leukocytes providing the first line of defence against infections in ischemic stroke. In 49 patients with acute ischemic events and 61 healthy subjects (HS), we examined LAR, astroglia specific S100B indicating the extent of brain tissue damage and hsCRP within 6 hours, as well as 24 and 72 hours after onset of symptoms. Serum levels of hsCRP on admission was significantly higher in patients with acute ischemic stroke (AIS) compared to HS and were higher in patients with recurrent to first ever ischemic stroke. Increased basal levels of hsCRP also correlated with severity of stroke and extent of infarct reflected by S100B levels in sera, but did not correlate with post-stroke infections. However, a higher rate of infection was observed among patients, in whom hsCRP was elevated at 72 hours but LAR did not increase. Therefore, such late elevation of hsCRP may indicate pre-clinical infections due to deficient leukocyte activation. Simple tests like LAR and hsCRP may help in predicting outcome and high risk of infectious complications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364064     DOI: 10.3233/CH-2010-1273

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  6 in total

Review 1.  Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns.

Authors:  Alejandro Bustamante; Alba Simats; Andrea Vilar-Bergua; Teresa García-Berrocoso; Joan Montaner
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

2.  Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke.

Authors:  George Füst; Lea Munthe-Fog; Zsolt Illes; Gábor Széplaki; Tihamér Molnar; Gabriella Pusch; Kristóf Hirschberg; Robert Szegedi; Zoltán Széplaki; Zoltán Prohászka; Mikkel-Ole Skjoedt; Peter Garred
Journal:  J Neuroinflammation       Date:  2011-12-29       Impact factor: 8.322

3.  Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis.

Authors:  Hanna Pawluk; Grzegorz Grześk; Renata Kołodziejska; Mariusz Kozakiewicz; Alina Woźniak; Elżbieta Grzechowiak; Maciej Szumny; Piotr Sobolewski; Leszek Bieniaszewski; Grzegorz Kozera
Journal:  Clin Interv Aging       Date:  2020-08-06       Impact factor: 4.458

4.  Relationship between leukocyte counts and large vessel occlusion in acute ischemic stroke.

Authors:  Gabor Tarkanyi; Zsofia Nozomi Karadi; Zsofia Szabo; Istvan Szegedi; Laszlo Csiba; Laszlo Szapary
Journal:  BMC Neurol       Date:  2020-12-04       Impact factor: 2.474

5.  Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke.

Authors:  Dora Spantler; Peter Csecsei; Katalin Borocz; Timea Berki; Laszlo Zavori; Attila Schwarcz; Gabor Lenzser; Tihamer Molnar
Journal:  Diagnostics (Basel)       Date:  2022-08-11

6.  Novel Predictors of Future Vascular Events in Post-stroke Patients-A Pilot Study.

Authors:  Diana Schrick; Erzsebet Ezer; Margit Tokes-Fuzesi; Laszlo Szapary; Tihamer Molnar
Journal:  Front Neurol       Date:  2021-06-18       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.